After excluding patients on antistaphylococcal antibiotics with a concurrent infection, those who had a 1-time dose of antibiotic, and those who discontinued antibiotics prior to receipt of rPCR ...

Conclusion: Patients receiving antibiotics for greater than two days and patients with a central line were more likely to have a true bloodstream infection with coagulase negative Staphylococci.

Conclusion: Patients receiving antibiotics for greater than two days and patients with a central line were more likely to have a true bloodstream infection with coagulase negative Staphylococci.

As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive ...

While staph normally lives in the nose or on the skin of some healthy individuals without consequence, infections can cause abscesses, cellulitis, or other skin concerns, and can less commonly infect ...

Clinical question: Is there a mortality difference between early transition to oral antibiotics versus prolonged intravenous antibiotics in uncomplicated gram-negative bacteremia? Background: Although ...

Opens in a new tab or window A 7-day course of antibiotics for patients hospitalized ... and those with infections caused by Staphylococcus aureus. "You have to decide whether you think you ...

aureus The patient with exudative tonsillitis due to coagulase-positive Staph. aureus became afebrile in twenty-four hours. Throat cultures were negative for Staph. aureus at forty-eight and ...

Sample identification showed that all staphylococci were coagulase-negative and none was identified as S. aureus. Individual analysis of the 540 periodontal sites showed an occurrence of staphylococci ...

A 7-day course of antibiotics for patients hospitalized ... and those with infections caused by Staphylococcus aureus. "You have to decide whether you think you can generalize [these findings ...

Three of these six pathogens are antibiotic-resistant Gram-negative bacteria. Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13 ...